Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study of the Use of Gabapentin and Osteopathic Manipulative Medicine to Treat Fibromyalgia

NCT01107574 is registered in ClinicalTrials.gov with Good Samaritan Regional Medical Center, Oregon as lead sponsor.

NCT NCT01107574
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01107574 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study of the Use of Gabapentin and Osteopathic Manipulative Medicine to Treat Fibromyalgia
Lead sponsor
Good Samaritan Regional Medical Center, Oregon
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2004
Completion date
April 30, 2010
Enrollment
41 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fibromyalgia